Lecigon development status

Lecigon development status 2018-10-08T15:21:02+00:00

Sweden and EU

  • Lobsor´ s near-term focus is to obtain market authorization in the Nordic countries and key markets in Europe.
  • Lecigon®, has been granted marketing authorization by the Swedish Medical Agency by Oct 5th 2018. Process of obtaining pricing and reimbursement approval in Sweden is ongoing.

US and Canada

  • A newly formed US based company, Intrance Medical Systems Inc. is responsible for development and commercialization of Lecigon in the US and Canada.

Welcome to Lobsor Pharmaceuticals

The product information presented on this website is intended for healthcare professionals only. By clicking “I accept” you will be presented with the information.